Rowley Law PLLC is investigating potential claims against Osiris Therapeutics, Inc. and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Smith & Nephew plc. Stockholders will receive $19.00 for each share of Osiris Therapeutics, Inc. stock that they hold. The transaction is valued at approximately $660.5 million and is expected to close in the second quarter of 2019.
If you are a stockholder of Osiris Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/osiris. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Date: March 18, 2019
Source: Cision
